Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Seminars in Oncology
|
October 11, 1991
National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo
R C Benson, E D Crawford, M A Eisenberger, et al.
The Journal of Urology
|
June 1, 1988
The clinical significance of unconventional orchiectomy approaches in testicular cancer: a report from the Testicular Cancer Intergroup Study
J K Giguere, D M Stablein, J T Spaulding, et al.
Cancer
|
December 15, 1993
The use of flutamide in hormone-refractory metastatic prostate cancer
D G McLeod, R C Benson, M A Eisenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1983
Weekly doxorubicin in endocrine-refractory carcinoma of the prostate
F M Torti, D Aston, B L Lum, et al.
Urology
|
August 1, 1995
The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer
P Narayan, V Gajendran, S P Taylor, et al.
Seminars in Oncology
|
October 1, 1994
Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036
M A Eisenberger, E D Crawford, M Wolf, et al.
The Journal of Urology
|
June 1, 1991
Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study
D G McLeod, R B Weiss, D M Stablein, et al.
Cancer
|
September 1, 1990
Leuprolide with and without flutamide in advanced prostate cancer
E D Crawford, B A Blumenstein, P J Goodman, et al.
Cancer
|
December 1, 1985
A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinoma
F M Torti, L D Shortliffe, S K Carter, et al.
The Journal of Urology
|
November 1, 1984
The extent of surgery after chemotherapy for advanced germ cell tumors
F S Freiha, L D Shortliffe, R V Rouse, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Seminars in Oncology
|
October 11, 1991
National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo
R C Benson, E D Crawford, M A Eisenberger, et al.
The Journal of Urology
|
June 1, 1988
The clinical significance of unconventional orchiectomy approaches in testicular cancer: a report from the Testicular Cancer Intergroup Study
J K Giguere, D M Stablein, J T Spaulding, et al.
Cancer
|
December 15, 1993
The use of flutamide in hormone-refractory metastatic prostate cancer
D G McLeod, R C Benson, M A Eisenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1983
Weekly doxorubicin in endocrine-refractory carcinoma of the prostate
F M Torti, D Aston, B L Lum, et al.
Urology
|
August 1, 1995
The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer
P Narayan, V Gajendran, S P Taylor, et al.
Seminars in Oncology
|
October 1, 1994
Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036
M A Eisenberger, E D Crawford, M Wolf, et al.
The Journal of Urology
|
June 1, 1991
Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study
D G McLeod, R B Weiss, D M Stablein, et al.
Cancer
|
September 1, 1990
Leuprolide with and without flutamide in advanced prostate cancer
E D Crawford, B A Blumenstein, P J Goodman, et al.
Cancer
|
December 1, 1985
A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinoma
F M Torti, L D Shortliffe, S K Carter, et al.
The Journal of Urology
|
November 1, 1984
The extent of surgery after chemotherapy for advanced germ cell tumors
F S Freiha, L D Shortliffe, R V Rouse, et al.
Page
of 3